Ongoing
Early lung cancer detection
Acronym
TIME4LUNG
Duration
Oct 2026 – Sep 2029
Funded by
COMPETE 2030
Status
Ongoing
Synopsis / Objectives
Develop, validate and prepare the clinical deployment of Optomics®, a technology combining photonics, biotechnology and AI to generate lung cancer risk scores from a simple blood sample. About 10 000 high-risk individuals will be recruited in Portuguese hospitals, building a multimodal dataset (Optomics®, multi-omics, clinical and imaging data).